Aix Marseille University, INSERM 1263, INRAE, C2VN, Marseille, France.
Aix Marseille University, INSERM 1263, INRAE, C2VN, Marseille, France; Department of Digestive Surgery, Timone University Hospital, Marseille, France.
Thromb Res. 2020 Jul;191 Suppl 1:S112-S116. doi: 10.1016/S0049-3848(20)30407-2.
The cancer-thrombosis relationship has been established for decades, in both cancer biology and in the clinical signs and symptoms seen in cancer patients (thrombosis in cancer patients has been associated with a worse prognosis and survival). As the link between the pathologies becomes clearer, so does the need to develop models that enable researchers to study them simultaneously in vivo. Mouse models have often been used, and they have helped determine molecular pathways between cancer spread and thrombosis in humans. This review is a summary of the current literature that describes the use of cancer mouse models in thrombosis research. We included cancer models that are not yet used in thrombosis research, but that can positively impact this area of research in the near future. We describe the most commonly used techniques to generate thrombosis as well as the mouse strains and cancer cell types that are commonly used along with inoculation techniques. We endeavoured to create a compendium of the different mouse models that are beneficial for cancer-thrombosis research, as understanding these mechanisms is crucial for creating better and more effective treatments for thrombosis in cancer patients.
癌症与血栓形成的关系已经存在了几十年,无论是在癌症生物学领域,还是在癌症患者的临床症状和体征中(癌症患者的血栓形成与预后不良和生存率降低有关)。随着这些病理之间的联系变得更加清晰,开发能够使研究人员在体内同时研究它们的模型的需求也变得更加迫切。小鼠模型经常被使用,它们有助于确定癌症扩散和人类血栓形成之间的分子途径。这篇综述总结了目前描述在血栓形成研究中使用癌症小鼠模型的文献。我们纳入了尚未用于血栓形成研究但在不久的将来可能会对该研究领域产生积极影响的癌症模型。我们描述了最常用于生成血栓的技术,以及常用的小鼠品系和癌细胞类型,以及接种技术。我们努力创建一个对癌症-血栓形成研究有益的不同小鼠模型的纲要,因为了解这些机制对于为癌症患者的血栓形成创造更好、更有效的治疗方法至关重要。